SCHEMBL5456043

SCHEMBL5456043

COc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ncccc3C)CC2)c(F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.58
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
KDM4E B2RXH2 2/20 0.52
TSHR P16473 2/20 0.52
USP2 O75604 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MAPT P10636 3/20 0.50
HTR1A P08908 4/20 0.49
HTR1D P28221 4/20 0.49
HTR1B P28222 4/20 0.49
HTR2C P28335 2/20 0.49
HTR6 P50406 2/20 0.49
MAPK1 P28482 1/20 0.48
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.46
P2RX7 Q99572 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464794 0.91 GFER (0.59) GFERALDH1A1MEN1KMT2AKDM4E
SCHEMBL5460067 0.89 ALDH1A1 (0.49) GFERALDH1A1MEN1KMT2AKDM4E
SCHEMBL5458255 0.87 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL5473571 0.84 TRPV1 (0.49) MEN1KMT2ATSHRMAPTMAPK1
SCHEMBL5549915 0.82 MEN1 (0.64) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL5459980 0.80 GFER (0.62) GFERALDH1A1MEN1KMT2AKDM4E
SCHEMBL5458483 0.79 MEN1 (0.59) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL5467111 0.79 MAPT (0.51) GFERALDH1A1MEN1KMT2AKDM4E
SCHEMBL5453308 0.79 GFER (0.53) GFERALDH1A1MEN1KMT2AKDM4E
SCHEMBL5467463 0.79 GFER (0.51) GFERALDH1A1KDM4ETSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 GFER 1367/4885ALDH1A1 731/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.